Oncology Research and Treatment

Article	Citations
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	29
uGI: Biomaker-Cut-Offs in der Immunonkologie	27
Front & Back Matter	24
PharmaNews	19
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab	12
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	11
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	10
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	9
Real world experiences in the treatment of immune thrombocytopenia over a two-year period	9
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer	9
Career and Professional Development for Young Oncologists	8
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study	8
Society Bulletins	8
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	8
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	8
Society Bulletins	7
PharmaNews	7
OnkoImmun 21	7
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?	7
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	7
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem	7
PharmaNews	6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine	6
Front & Back Matter	6
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz	6

Three therapeutic modalities for advanced ovarian cancer: real world data from a certified oncological center	6
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer	5
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report	5
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology	5
Capivasertib/Fulvestrant bei ER+/HER2– MBC	5
DKK 2024: Acalabrutinib im Praxis-Check	5
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany	5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	5
PharmaNews	5
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative	5
Erratum	5
PharmaNews	4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	4
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	4
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation	4
Society Bulletins	4
Vorwort des DGHO-Vorstands	4
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	4
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	4
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi	4
Epcoritamab: Indikationserweiterung für das FL	4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	4
PharmaNews	4
Management of Advanced Penile Cancer	4
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models	4
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer	3
Oncology in Europe	3
OnkoImmun 19	3
Front & Back Matter	3
Society Bulletins	3
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Society Bulletins	3
Perspectives for Cancer Care and Research in Central and Eastern Europe	3
Society Bulletins	3
Acknowledgement to Reviewers	3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	3
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines	3
Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study	3
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	3
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey	3
Erweiterte Therapieoptionen bei EGFRm NSCLC	2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers	2
Prognostic Significance of HER2 Positivity in Endometrium Cancer	2
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer	2
OnkoImmun 18	2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy	2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	2

Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy	2
Front & Back Matter	2
PharmaNews	2
Society Bulletins	2
Prelims	2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie	2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	2
Management of Patients Undergoing CAR-T Cell Therapy in Germany	2
Prelims	2
Contents Vol. 47, 2024	2
Moving Tumor-Agnostic Therapy to the Big Stage: Translational and Molecular Oncology Highlights from the ESMO Congress 2025	2
Front & Back Matter	2
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines	2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich	2
PharmaNews	2
Guidelines of Onkopedia: What Is New?	2
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel	1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast	1
Allogeneic Hemopoietic Cell Transplantation as a Paradigm for Cellular Immunotherapy	1
Paclitaxel/Ramucirumab versus Paclitaxel in 2nd-Line Therapy of Advanced Esophageal Squamous Cell Carcinoma: Randomized Phase II IKF-AIO-RAMOS Trial	1
Multiples Myelom – Therapie mit Melflufen	1
PharmaNews	1
PharmaNews	1
Society Bulletins	1
Society Bulletins	1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC	1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries	1
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer	1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis	1
Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Pla	1
CLL: Daten bestätigen Nutzen von Venetoclax-Kombinationstherapien	1
PharmaNews	1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	1
PharmaNews	1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022	1
Society Bulletins	1
PharmaNews	1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018	1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment	1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres	1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma	1
A Multicentre, Randomized Trial in Adults with de novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia to Assess the Efficacy of Ponatinib versus Imatinib in Combination with Low-Intens	1
Iptacopan: Erste orale PNH-Monotherapie	1
Society Bulletins	1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	1
Prelims	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies	1
Society Bulletins	1
Onkologische Patient*innen individuell behandeln und begleiten	1
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review	1
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism	0
Society Bulletins	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study	0
Society Bulletins	0
Use of Follow-Up Psycho-Oncology Consultations in Urological Cancer after Transition from Inpatient to Outpatient Care	0
Effektive Therapieoption: Pegcetacoplan bei PNH	0
PharmaNews	0
Osimertinib: Hohe Wirksamkeit im Zentralnervensystem	0
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg	0
PharmaNews	0
2025 ASCO Bladder Cancer Highlights	0
A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors	0
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Society Bulletins	0
Chemoimmuntherapie als ein Standard bei ED-SCLC	0
Society Bulletins	0
Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021	0
Frontline Pembrolizumab or Methotrexate in Elderly, Frail, or Cisplatin-Ineligible Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of the Randomized Phase 2	0
Treatment Satisfaction and Treatment Wishes of Patients with Chronic Cancer-Related Pain	0
Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer	0
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation	0
Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-Invasive Bladder Cancer	0
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
Before-and-after Studies in Oncology: How Real Is the Real-World Evidence?	0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review	0

Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement	0
PharmaNews	0
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network	0
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group	0
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Report	0
Society Bulletins	0
Safety and Preliminary Activity of Neoadjuvant Trastuzumab Deruxtecan plus 5-Fluorouracil and Folinic Acid for HER2-Positive, Resectable Esophagogastric Adenocarcinoma: Results from the Safety Run-In	0
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience	0
Society Bulletins	0
Managing Antithrombotic Treatment in Patients with Immune Thrombocytopenia	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC	0
Society Bulletins	0
Safety of Surgery within 24 h following Colonoscopy for Colorectal Cancer: A Retrospective Propensity Scores Matched Analysis	0
PharmaNews	0
Efficacy and Safety of Prophylactic Tocilizumab in Patients with Multiple Myeloma Receiving Bispecific Antibodies: A Systematic Review and Meta-Analysis	0
PharmaNews	0
Paraneoplastic Papillitis as a Precursor to Colon Carcinoma: A Case of Unexpected Vision Loss Leading to Early Cancer Detection	0
Prelims	0
Albert Schweitzer, Chronic Myeloid Leukemia, and War	0
Treatment of Advanced or Metastatic Urothelial Cancer	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
What Is New in the German S3 Guideline on Gastric Cancer: Diagnosis, Staging, and Treatment	0
Abemaciclib beim eBC und mBC	0
Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic	0
Vorteile des MAIA-Regimes bei Hochrisikozytogenetik	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database	0
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data	0
Effectiveness and Safety of Combining Transarterial Chemoembolization with Tyrosine Kinase and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Meta-Analysis	0
Fortgeschrittenes oder nicht resezierbares HCC: explorative 4-Jahres-Analyse STRIDE	0
PharmaNews	0
Geriatric Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024	0
The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvan	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:	0
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany	0
Momelotinib bei Myelofibrose und Anämie	0
TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma	0
Retraction Statement	0
Anti-HER2/Neu Antibody Therapy Inhibits HER2 + Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity	0
PharmaNews	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)	0
Society Bulletins	0
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
PharmaNews	0
(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary – Highlights from ESMO 2025 and the First International Cancer of Unknown Primary Meeting	0
Barriers and Facilitators in Continuous Medical Education Related to Allogeneic Stem Cell Transplantation: A Qualitative Study of Physicians	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
PharmaNews	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers	0
Management of Advanced Germ Cell Tumours	0
mNSCLC - Leitlinie empfiehlt POSEIDON-Regime	0
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem-Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer Centers	0
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case	0
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review	0
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice	0
Prelims	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0
Real-World-Evidenz für Daratumumab-CyBorD bei AL-Amyloidose	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients	0
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis	0
Systematic Evaluation of Vitamin D and the Risk of Breast Cancer Development	0
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases	0
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation	0
PharmaNews	0
The Critical Role of Sex and Gender in Medicine	0
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie	0
Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging	0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy	0
Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells – Insights from Healthy Donors Compared to Gastric Cancer Patients	0
Supportive Therapie bei Krebs: AGSMO Jahreskongress 2025, 24. Mai 2025, Berlin und online – Abstracts	0
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome	0
Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy	0
Verlässliche Immuntherapie in der Versorgungsrealität	0
PharmaNews	0
Society Bulletins	0
PharmaNews	0
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas	0
Highlights from ESMO 2024 as a Young Head and Neck Oncologist	0
Society Bulletins	0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom	0
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future Directions	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0
Molecular Tissue Profiling in a Clinically Selected Pancreatic Cancer Cohort	0
The Path to Clinical Implementation of DPYD Pharmacogenetic Testing: Long-Term Experience from an External Quality Assessment Provider and a University Testing Center	0
A Real-World Evaluation of Brain Imaging in Patients with Advanced Non-Small Cell Lung Cancer: Insights from a German Claims Data Analysis	0
r/r DLBCL: Heilungschance mit Axi-Cel	0
Neu bei mCRPC: Talazoparib + Enzalutamid	0
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma	0